Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Allon

Showing results (171-180 of 201) with videos related to

Pageof 21
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|September 1, 2016
Preoperative Vascular Medial Fibrosis and Arteriovenous Fistula DevelopmentYan-Ting Shiu, Silvio H Litovsky, Alfred K Cheung, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 7, 2007
Association between serum 2-microglobulin level and infectious mortality in hemodialysis patientsAlfred K Cheung, Tom Greene, John K Leypoldt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2009
Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of AmericaLeonard A Mermel, Michael Allon, Emilio Bouza, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 1, 2018
Clinical Trial End Points for Hemodialysis Vascular Access: Background, Rationale, and DefinitionsSurendra Shenoy, Michael Allon, Gerald Beathard, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 17, 2005
The spectrum of infection-related morbidity in hospitalized haemodialysis patientsMichael Allon, Milena Radeva, James Bailey, et al.
Journal of the American Society of Nephrology : JASN|September 30, 2005
Association of achieved dialysis dose with mortality in the hemodialysis study: an example of "dose-targeting bias"Tom Greene, John Daugirdas, Thomas Depner, et al.
Seminars in Dialysis|October 6, 2004
Improving outcomes in CKD and ESRD patients: carrying the torch from training to practiceAllen R Nissenson, Rajiv Agarwal, Michael Allon, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2003
Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO StudyMichael Allon, Thomas A Depner, Milena Radeva, et al.
Kidney International|April 17, 2004
Dialysis dose and the effect of gender and body size on outcome in the HEMO StudyThomas Depner, John Daugirdas, Tom Greene, et al.
Radiology|December 24, 2015
Arteriovenous Fistula Development in the First 6 Weeks after CreationMichelle L Robbin, Tom Greene, Alfred K Cheung, et al.
Pageof 21

Showing results (171-180 of 201) with videos related to

Sort By:
Pageof 21
Clinical Journal of the American Society of Nephrology : CJASN|September 1, 2016
Preoperative Vascular Medial Fibrosis and Arteriovenous Fistula DevelopmentYan-Ting Shiu, Silvio H Litovsky, Alfred K Cheung, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 7, 2007
Association between serum 2-microglobulin level and infectious mortality in hemodialysis patientsAlfred K Cheung, Tom Greene, John K Leypoldt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2009
Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of AmericaLeonard A Mermel, Michael Allon, Emilio Bouza, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 1, 2018
Clinical Trial End Points for Hemodialysis Vascular Access: Background, Rationale, and DefinitionsSurendra Shenoy, Michael Allon, Gerald Beathard, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 17, 2005
The spectrum of infection-related morbidity in hospitalized haemodialysis patientsMichael Allon, Milena Radeva, James Bailey, et al.
Journal of the American Society of Nephrology : JASN|September 30, 2005
Association of achieved dialysis dose with mortality in the hemodialysis study: an example of "dose-targeting bias"Tom Greene, John Daugirdas, Thomas Depner, et al.
Seminars in Dialysis|October 6, 2004
Improving outcomes in CKD and ESRD patients: carrying the torch from training to practiceAllen R Nissenson, Rajiv Agarwal, Michael Allon, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2003
Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO StudyMichael Allon, Thomas A Depner, Milena Radeva, et al.
Kidney International|April 17, 2004
Dialysis dose and the effect of gender and body size on outcome in the HEMO StudyThomas Depner, John Daugirdas, Tom Greene, et al.
Radiology|December 24, 2015
Arteriovenous Fistula Development in the First 6 Weeks after CreationMichelle L Robbin, Tom Greene, Alfred K Cheung, et al.
Pageof 21